Molecular Templates Inc [MTEM] stock prices are saw in change for the day to $0.75 at the moment. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The MTEM shares have gain 92.36% over the last week, with a monthly amount drifted -44.44%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Molecular Templates Inc [NASDAQ: MTEM] stock has seen the most recent analyst activity on April 21, 2021, when BofA Securities initiated its Buy rating and assigned the stock a price target of $12. Previously, UBS started tracking the stock with Neutral rating on February 01, 2021, and set its price target to $13. On September 08, 2020, Jefferies initiated with a Buy rating and assigned a price target of $21 on the stock. Stifel started tracking the stock assigning a Buy rating and suggested a price target of $19 on March 25, 2020. Barclays initiated its recommendation with a Overweight and recommended $22 as its price target on February 27, 2020. UBS started tracking with a Buy rating for this stock on April 29, 2019, and assigned it a price target of $12. In a note dated December 11, 2018, Oppenheimer initiated an Outperform rating and provided a target price of $15 on this stock.
The stock price of Molecular Templates Inc [MTEM] has been fluctuating between $0.29 and $6.48 over the past year. Molecular Templates Inc [NASDAQ: MTEM] shares were valued at $0.75 at the most recent close of the market.
Analyzing the MTEM fundamentals
The Molecular Templates Inc [NASDAQ:MTEM] reported sales of 25.47M for trailing twelve months, representing a drop of -91.67%. Gross Profit Margin for this corporation currently stands at 0.8% with Operating Profit Margin at -0.34%, Pretax Profit Margin comes in at -0.29%, and Net Profit Margin reading is -0.29%. To continue investigating profitability, this company’s Return on Assets is posted at -0.27, Equity is -1.22 and Total Capital is -0.45. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of1.55.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.6903 points at the first support level, and at 0.6307 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.8198, and for the 2nd resistance point, it is at 0.8897.
Ratios To Look Out For
It’s worth pointing out that Molecular Templates Inc [NASDAQ:MTEM]’s Current Ratio is 1.56. Also, the Quick Ratio is 1.56, while the Cash Ratio stands at 1.26. Considering the valuation of this stock, the price to sales ratio is 0.19, the price to book ratio is 0.69.
Transactions by insiders
Recent insider trading involved BIOTECH TARGET N V, 10% Owner, that happened on Apr 02 ’24 when 0.25 million shares were purchased.
